Article
Characterization of m6A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma.
Frontiers in immunology - 1 Jan 2021
Zhu Minggao, Cui Yachao, Mo Qi, Zhang Junwei, Zhao Ting, Xu Yujie, Wu Zhenpeng, Sun Donglin, Zhang Xiaoren, Li Yingchang, You Qiang
Abstract excerpt
N6-methyladenosine (m6A) RNA modification is a reversible mechanism that regulates eukaryotic gene expression. Growing evidence has demonstrated an association between m6A modification and tumorigenesis and response to immunotherapy. However, the overall influence of m6A regulators on the tumor microenvironment and their effect on the response to immunotherapy in lung adenocarcinoma remains to be explored. Here,...
Topics
- Adenocarcinoma of Lung
- Adenosine
- Biomarkers, Tumor
- Computational Biology
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Immunomodulation
- Immunotherapy
- Kaplan-Meier Estimate
